Revalesio

Revalesio

WA - Tacoma
Biotechnology

Focus: Proprietary charge-stabilized nanostructure (CSN) technology

Revalesio is a life sciences company focused on Proprietary charge-stabilized nanostructure (CSN) technology.

Oncology
Open Jobs
0

Pipeline & Clinical Trials

Electro-kinetically Modified Water
Pelvic Pain
N/A
Clinical Trials (1)
NCT02523794Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis
N/A
Phase 1
Clinical Trials (1)
NCT01264783Safety and Tolerability of RNS60 Given by IV to Healthy Subjects
Phase 1
RNS60
Asthma
Phase 1
Clinical Trials (1)
NCT01511302Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
Phase 1
RNS60
Asthma
Phase 1
Clinical Trials (1)
NCT01057498Safety Study of Nebulized RNS60 to Treat Asthma.
Phase 1
Clinical Trials (1)
NCT02490865Systemic Bioactivity of Inhaled Nebulized RNS60
Phase 1
Revera Wound Care
Venous Stasis Ulcers
Phase 1
Clinical Trials (1)
NCT00823446Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers
Phase 1
Phase 2
Clinical Trials (1)
NCT04693715Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy
Phase 2
RNS60
Asthma
Phase 2
Clinical Trials (1)
NCT02422121Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge
Phase 2
RNS60
Asthma
Phase 2
Clinical Trials (1)
NCT02497222Pilot Study of RNS60 in Allergen-induced Bronchoconstriction
Phase 2
Clinical Trials (1)
NCT02988297Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis
Phase 2
Clinical Trials (1)
NCT01714089Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis
Phase 2
Phase 2
Clinical Trials (1)
NCT02005523Study of RNS60 on Pain and Function After Hip Labral Repair
Phase 2
Clinical Trials (1)
NCT01922427Study of RNS60 on Pain and Function After Knee Anterior Cruciate Ligament Surgery
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2019
Portfolio: 13 clinical trials